Advertisement
Screener

OBSIDIAN THERAPEUTICS, INC. (OBX) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

OBSIDIAN THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

OBSIDIAN THERAPEUTICS, INC. (OBX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-28

  • OBSIDIAN THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $0.00.
  • OBSIDIAN THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was -$11.00K.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2026-06-30$0.00
10-Q · filed 2026-08-14
-$26.00K
S-1 · filed 2026-08-28
2025-12-31$50.00K
S-1 · filed 2026-08-28
2025-06-30-$11.00K
S-1 · filed 2026-08-28
-$11.00K
S-1 · filed 2026-08-28
2024-12-31-$54.00K
S-1 · filed 2026-08-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Cryoport, Inc. (CYRX)United States$0.881B-21.29